tirzepatide w How the weight loss drug is also helping heart failure patients Most Successful Weight Loss Program. Tirzepatide Weight Loss Injections &

04 The added glucagon arm is retatrutide's distinctive feature, targeting energy expenditure and liver fat beyond GLP-1/GIP

Your GP Practice is committed to helping patients live healthier lives

SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks

It is the one that fits your specific situation, goals, medical history, and practical constraints

But the popularity of GLP-1 medications spiked after the approval of Ozempic in 2017

Most side effects are mild and settle within a few weeks